Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging

Université Laval

$50,000.00

Alteration of the microRNA pathway during the aging process

EF 2010-11

Résumé
Containing ~20,000 to 25,000 genes, the human genome may express more than ~200,000 messenger RNAs (mRNAs) that can be translated into more than ~2,000,000 different proteins, the main constituents of cells. A finely tuned regulatory control of gene expression is thus required in order to maintain homeostasis and to remain healthy. Recent studies unveiled the existence and biological significance of a gene regulatory mechanism of unprecedented importance based on tiny RNA species called microRNAs in almost all living eukaryotes, including humans. Generated by the ribonuclease III Dicer, an enzyme that we discovered, microRNAs, formed by only 21 to 24 building blocks known as nucleotides, may regulate up to 90% of the genes! This observation suggests that every metabolic processes may be under microRNA control in all cells and tissues of the human body. Given their recognized importance in finely tuning gene expression in humans, one can anticipate that microRNAs will play a significant role in health and disease, i.e. a deregulated protein expression induced by a dysfunctional microRNA-based regulatory system is expected to lead to the development of serious genetic diseases. One aspect that has yet to receive any consideration is the functioning of the microRNA machinery in the elderly and how this gene regulatory process evolve and may be affected during the aging process. In this proposal, we wish to investigate the effects of several classes of chemical agents and stresses, to which our body is exposed during our lifetime, that may alter the ability of microRNAs to regulate gene expression, and thus contribute to the aging process. Realization of this proposal may provide the basis for more elaborated studies designed to improve our understanding of how the microRNA machinery may be affected during the course of aging and of the relationship between microRNAs, aging and diseases.
Programme
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
228780
Name
Provost Patrick
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Institute of Aging Pilot Projects
Projecttitle
Alteration of the microRNA pathway during the aging process
Programtype2
Operating Grants
Orgnameinp2
Université Laval
Cihramount2
$50,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Pilot Projects in Aging - Biological & Clinical Aspects of Aging
Keyworddelim
Aging; Argonaute 2; Biochemistry; Cell Culture; Chemical Agents; Dicer; Gene Regulation; Microrna; Molecular Biology; Rna Silencing
Abstract
Containing ~20,000 to 25,000 genes, the human genome may express more than ~200,000 messenger RNAs (mRNAs) that can be translated into more than ~2,000,000 different proteins, the main constituents of cells. A finely tuned regulatory control of gene expression is thus required in order to maintain homeostasis and to remain healthy. Recent studies unveiled the existence and biological significance of a gene regulatory mechanism of unprecedented importance based on tiny RNA species called microRNAs in almost all living eukaryotes, including humans. Generated by the ribonuclease III Dicer, an enzyme that we discovered, microRNAs, formed by only 21 to 24 building blocks known as nucleotides, may regulate up to 90% of the genes! This observation suggests that every metabolic processes may be under microRNA control in all cells and tissues of the human body. Given their recognized importance in finely tuning gene expression in humans, one can anticipate that microRNAs will play a significant role in health and disease, i.e. a deregulated protein expression induced by a dysfunctional microRNA-based regulatory system is expected to lead to the development of serious genetic diseases. One aspect that has yet to receive any consideration is the functioning of the microRNA machinery in the elderly and how this gene regulatory process evolve and may be affected during the aging process. In this proposal, we wish to investigate the effects of several classes of chemical agents and stresses, to which our body is exposed during our lifetime, that may alter the ability of microRNAs to regulate gene expression, and thus contribute to the aging process. Realization of this proposal may provide the basis for more elaborated studies designed to improve our understanding of how the microRNA machinery may be affected during the course of aging and of the relationship between microRNAs, aging and diseases.
Competitiondate
201009
Approvedterm2
1 yr 0 mth
Pinamesdelim
Provost, Patrick
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $12,500~ $0~Institute of Aging~ $37,500~ $0~